| 注册
首页|期刊导航|中国临床药理学杂志|醒脑静注射液治疗创伤性脑出血患者的临床研究

醒脑静注射液治疗创伤性脑出血患者的临床研究

张平文 王义宣

中国临床药理学杂志2023,Vol.39Issue(23):3351-3355,5.
中国临床药理学杂志2023,Vol.39Issue(23):3351-3355,5.DOI:10.13699/j.cnki.1001-6821.2023.23.002

醒脑静注射液治疗创伤性脑出血患者的临床研究

Clinical trial of Xingnaojing injection in the treatment of patients with traumatic intracerebral hemorrhage

张平文 1王义宣1

作者信息

  • 1. 吉安市中心人民医院 急诊科,江西 吉安 343000
  • 折叠

摘要

Abstract

Objective To observe the effects of Xingnaojing injection on endoplasmic reticulum stress,cerebral edema degree and neurological function in patients with traumatic intracerebral hemorrhage.Methods Patients with traumatic intracerebral hemorrhage were randomly divided into treatment group and control group according to the random number table method.The control group received conventional treatment for traumatic intracerebral hemorrhage,and the treatment group was intravenously given Xingnaojing injection 20 mL,once a day on the basis of the control group.Both groups of patients were treated continuously for 14 d.The clinical efficacy and endoplasmic reticulum stress indicators,cerebral edema degree and neurological function before and after treatment were compared between the two groups of patients,and the adverse drug reactions were analyzed.The prognosis was evaluated at 6 months after treatment.Results Two cases were shed during treatment,thus 52 cases in treatment group and 50 cases in control group were finally included.After treatment,the total effective rate in treatment group and control group were 92.31%(48 cases/52 cases)and 78.00%(39 cases/50 cases),with significant difference(P<0.05).After treatment,serum glucose-regulatory protein 78(GRP78)in treatment group and control group were(10.42±2.14)and(14.49±2.62)μg·L-1;CCAAT/enhancer binding protein(CHOP)were(821.38±186.43)and(992.46±216.18)μg·L-1;caspase-12 were(82.42±15.17)and(96.08±20.01)pmol·L-1;hematoma volume were(6.48±2.68)and(9.14±3.13)mL;edema volume were(2.76±0.82)and(3.59±0.87)mL;National Institutes of Health Stroke Scale(NIHSS)score were 6.72±2.08 and 8.84±2.21;the European Stroke Scale(ESS)were 65.31±8.43 and 61.69±7.92,the differences were all statistically significant(all P<0.05).The incidence of adverse drug reactions in treatment group and control group were 15.38%(10 cases/52 cases)and 8.00%(4 cases/50 cases),with no statistical significance(P>0.05).Six months after treatment,the recovery rate of treatment group and control group were 69.23%(36 cases/52 cases)and 50.00%(25 cases/50 cases),the difference was statistically significant(P<0.05).Conclusion Xingnaojing injection has good clinical efficacy and safety in the treatment of patients with traumatic intracerebral hemorrhage.It can improve the endoplasmic reticulum stress level,relieve the degree of cerebral edema,further promote the recovery of neurological function,and improve the prognosis of patients.

关键词

醒脑静注射液/创伤性脑出血/内质网应激/脑水肿/神经功能

Key words

Xingnaojing injection/traumatic intracerebral hemorrhage/endoplasmic reticulum stress/cerebral edema/neurological function

分类

医药卫生

引用本文复制引用

张平文,王义宣..醒脑静注射液治疗创伤性脑出血患者的临床研究[J].中国临床药理学杂志,2023,39(23):3351-3355,5.

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文